Hodgkin lymphoma, also known as Hodgkin's lymphoma or Hodgkin's disease, is a type of lymphoma, in which cancer originates from white blood cells called lymphocytes.
Biotherapy options have emerged for patients with B-lineage Non-Hodgkins Lymphoma (NHL). A series of novel mAbs with specificity for a variety of surface antigens are currently under evaluation. Rituximab used both for biotherapy of patients with B-lineage NHL who experience a recurrence of their disease after frontline therapy as well as for frontline treatment of B-lineage NHL patients who are at high risk to experience a recurrence after chemotherapy. Hodgkin Lymphoma (HL) shows a 3rd month anti-TNF therapy which needs to be modified and pursue immunosuppressive therapy with anti-TNF drugs, which were also used in the treatment of rheumatic diseases.
Scientific journal is a periodical publication intended to further progress of science, usually by reporting novel research. There are thousands of scientific journals in publication, and many more have been published at various points in the past. Most journals are highly specialized, although some of the oldest journals publish articles and scientific papers across a wide range of scientific fields. Scientific journals contain articles that are peer reviewed, to ensure that articles meet the journal's standards of quality, and scientific validity. The publication of the results of research is an essential part of the scientific method. If they are describing experiments or calculations, they must supply enough details that an independent researcher could repeat the experiment or calculation to verify the results. Each such journal article becomes part of the permanent scientific record.
Last date updated on September, 2014